A Reversal on Sequencing? Proposed Legislation Would Allow Patenting of Naturally Occurring Genes
FDA Law
OCTOBER 24, 2024
In a landmark 2013 decision , a unanimous Supreme Court held that a naturally occurring DNA segment, even when isolated, is a product of nature and therefore does not meet the subject matter eligibility requirement for patentability. HPM is currently representing AMP in unrelated litigation.) Cook-Deegan et al.
Let's personalize your content